ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Ohio State to study center expansion.

September 26, 2003

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

Funding NCI Bypass Budget The “Very Least” Congress Could Do, Congressman Durbin Says

July 13, 1990

Symposium Addresses FCC issues

February 21, 1986